CVS Health Corp.

CVS Health Corp.

CVS
CVS Health Corp.US flagNew York Stock Exchange
94.66
USD
-0.63
- -
120.78BMarket Cap
CVS Health Corp.
CVS
(New York Stock Exchange)

Recent

price

94.66

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
70.06
80.03
96.87
104.16
120.04
137.11
165.47
181.16
186.38
197.37
205.28
221.46
245.78
278.42
296.12
317.34
326.13
Revenue per Share
2.51
2.59
3.04
3.77
4
4.68
4.96
6.49
-0.57
5.1
5.48
6.07
3.29
6.49
3.66
1.4
3.84
Basic EPS, GAAP
2.03
2.98
3.65
3.12
5.17
5.52
7.38
5.97
6.54
7.99
10.26
11.94
10.25
8.09
5.02
6.16
9.24
Free Cash Flow per Basic Share
0.35
0.5
0.65
0.9
1.11
1.41
1.71
2.01
1.95
2
2
1.99
2.22
2.44
2.68
2.68
2.68
Dividend per Share
27.66
29.29
30.59
32.15
33.3
33.78
34.71
37.17
44.96
49.05
52.97
56.79
54.98
59.36
59.97
59.18
62.36
Book Value per Share
1.65
1.31
1.22
1.58
0.04
-13.43
-14.07
-14.19
-44
-37.64
-31.53
-25.02
-24.22
-34.2
-34.15
-28.14
-23.8
Tangible Book Value per Share
1,367
1,338
1,271
1,217
1,161
1,118
1,073
1,020
1,044
1,301
1,309
1,319
1,312
1,285
1,259
1,267
1,273
Basic Weighted Avg Shares
95,778
107,080
123,120
126,761
139,367
153,290
177,546
184,786
194,579
256,776
268,706
292,111
322,467
357,776
372,809
402,067
415,086
Sales/Revenue/Turnover
6.41
5.91
5.86
6.34
6.31
6.18
5.85
5.26
5.23
4.76
5.18
5.17
5.05
4.08
2.6
2.58
3.38
Operating Margin (%)
1,469
1,568
1,753
1,870
1,931
2,092
2,475
2,479
2,718
4,371
4,441
4,486
4,224
4,366
4,597
4,606
4,522
Depreciation Expense
3,427
3,462
3,864
4,592
4,644
5,237
5,317
6,622
-594
6,634
7,179
8,001
4,311
8,344
4,614
1,768
4,890
Net Income, GAAP
38.9
39.29
38.64
38.89
39.5
39.3
38.4
19.8
142.39
26.3
26.29
24.18
25.86
25.11
25.41
19.1
15.59
Effective Tax Rate (%)
3.58
3.23
3.14
3.62
3.33
3.42
2.99
3.58
-0.31
2.58
2.67
2.74
1.34
2.33
1.24
0.44
1.18
Profit Margin (%)
6,636
6,638
6,011
9,900
6,956
5,989
4,792
581
1,234
-3,001
-5,648
-7,799
-3,788
-11,331
-15,964
-13,978
-11,695
Working Capital
8,652
9,208
9,133
12,841
11,630
26,267
25,615
22,181
71,444
83,625
77,964
70,148
67,276
74,672
75,426
74,145
72,434
LT Debt
37,734
38,051
37,653
37,938
37,963
37,203
36,834
37,695
58,543
64,170
69,701
75,381
71,769
76,636
75,730
75,382
79,899
Total Equity
7.92
8.02
9.26
9.94
10.42
9.96
9.92
12.08
-4.38
6.32
6.66
7.48
8.22
7.33
4.6
5.35
7.48
Return on Invested Capital (%)
7.94
7.98
8.81
9.93
9.82
9.97
9.27
11.58
-1.73
6.22
6.05
6.48
4.08
6.91
4.35
2.76
4.75
Return on Capital (%)
9.33
9.14
10.21
12.15
12.24
13.94
14.37
17.77
-1.24
10.87
10.77
11.08
5.88
11.28
6.07
2.35
6.23
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
5,805
4,484
3,872
LT Borrowings
60,502
60,531
59,452
LT Finance Leases
13,643
13,330
12,982
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,271
1,273
1,278
Market Capitalization
100,867
91,427
132,209

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
74,714
74,817
75,346
Cash, Cash Equivalents & STI
10,598
11,802
13,958
Accounts Receivable, Net
16,316
20,144
19,380
Inventories
19,246
17,770
17,622
Total Current Liabilities
88,692
86,406
87,041
Payables & Accruals
81,771
80,847
82,160
ST Debt
5,805
4,484
3,872
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
8.34%
1.7%
-0.46%
Free Cash Flow
6.3%
-7.15%
23.41%
Net Income, GAAP
-133.9%
-9.5%
-61.68%
Sales/Revenue/Turnover
10.39%
8.42%
7.85%
Total Cash Common Dividend
8.3%
5.38%
0.71%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
88,437
91,234
95,428
97,710
372,809
2025
94,588
98,915
102,871
105,693
402,067
2026
100,426
106,096
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.88
1.41
0.07
1.31
3.66
2025
1.41
0.81
-3.13
2.32
1.4
2026
2.31
2.33
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.67
0.68
0.66
0.67
2.68
2025
0.67
0.68
0.67
0.67
2.68
2026
0.67
0.69
- -
- -
- -
Business
CVS Health Corporation (CVS) operates as a diversified health solutions provider, offering integrated pharmacy, health insurance, and care services across the United States through segments including Health Care Benefits via Aetna, Pharmacy Services via CVS Caremark, and retail pharmacy operations; core products and services encompass retail pharmacies with over 9,600 locations selling prescription drugs, over-the-counter medications, health and wellness products, and general merchandise; MinuteClinic walk-in clinics providing diagnostic testing, vaccinations, and primary care; pharmacy benefit management including formulary management, claims processing, mail-order and specialty pharmacy, infusion services, and long-term care pharmacy consulting; Aetna health insurance plans covering medical, pharmacy, dental, behavioral health, and Medicare options for employers, individuals, and government programs; CVS Specialty for complex chronic disease therapies; and digital tools like mobile apps for prescription management and virtual care. Founded in 1963 and headquartered in Woonsocket, Rhode Island, the company serves approximately 100 million consumers nationwide with a workforce exceeding 300,000 colleagues, focusing on underserved communities through in-home, in-store, and virtual services. Recent developments include the completion in October 2025 of its acquisition of select Rite Aid and Bartell Drugs assets, adding 63 stores in Idaho, Oregon, and Washington plus prescription files from 626 pharmacies across 15 states to expand access for over 9 million patients; an expanded partnership with a major insurer announced in November 2025 to enhance service integration; and ongoing investments in pharmacy workforce hiring and training amid strong third-quarter 2025 financial performance with raised full-year guidance.

Company News

  • Baird Financial Group Inc. Acquires 10,059 Shares of CVS Health Corporation $CVS

  • Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?

  • CVS Health: Buy The Pullback Before Earnings Power Ramps Up

  • CVS Health Corporation (CVS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

  • CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom

  • Here's Why CVS Health (CVS) is a Strong Momentum Stock

  • CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

  • CVS Health marks 20 years of free community health screening program as new survey reveals many U.S. adults still face barriers to preventive health screenings

  • Wall Street Loves CVS Health Stock Right Now. Should You?

  • Richard Pzena Buys Globant SA (GLOB) -- Shares Look 78% Undervalued on GF Value

  • CVS Health Corporation $CVS Shares Sold by Continuum Advisory LLC

  • Here's How CVS Is Focusing on Aetna's Profitability Turnaround

  • Compass Financial Management LLC Buys Shares of 5,476 CVS Health Corporation $CVS

  • CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?

  • Here's Why CVS Health (CVS) is a Strong Growth Stock

  • Updated COVID-19 vaccines available at CVS Pharmacy and MinuteClinic across the U.S.

  • Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  • Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?

  • Here's How CVS' Improving Balance Sheet Supports Deleveraging

  • Why CVS Stock Rallied Tuesday Morning